Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

Upscale cliffside development The Palisades is on the hook for $1.7 million in fines from the Guam Environmental Protection Agency over a number of violations related to an Oct. 15 landslide that ...

While the complexity of the new display and materials may limit initial supply for several weeks, Apple is currently operating with a plan to put the device on sale around the same time — or very soon ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...